Skip to main content
Top
Published in: Endocrine 1/2013

01-08-2013 | Letter to the Editor

Wilson disease, genotype and infertility: is there a correlation?

Authors: Rim Frikha, Nouha Bouayed Abdelmoula, Tarek Rebai

Published in: Endocrine | Issue 1/2013

Login to get access

Excerpt

Wilson disease (WD; OMIM#277900) is a rare autosomal recessive disorder of copper metabolism, caused by mutations in the ATP7B gene (ATPase, Cu2+ transporting, beta polypeptide; OMIM#606882; 21 exons) and leading to hepatic or neurologic disease. The wide spectrum of symptoms in patients with Wilson’s disease raised the question whether these features are determined by the type of the ATP7B mutation. To date, more than 500 mutations have been identified in patients with Wilson disease [1], and genetic studies are also becoming available for clinical use, but the utility of direct mutation analysis is limited. In this report, we try to establish relationship between phenotype (WD) and genotype (mutation through ATP7B gene). …
Literature
1.
go back to reference S.M. Kenney, D.W. Cox, Sequence variation database for the Wilson disease copper transporter, ATP7B. Hum. Mutat. 28(12), 1171–1177 (2007)PubMedCrossRef S.M. Kenney, D.W. Cox, Sequence variation database for the Wilson disease copper transporter, ATP7B. Hum. Mutat. 28(12), 1171–1177 (2007)PubMedCrossRef
2.
go back to reference K. Jomova, M. Valko, Advances in metal-induced oxidative stress and human disease. Toxicology 283(2–3), 65–87 (2011)PubMedCrossRef K. Jomova, M. Valko, Advances in metal-induced oxidative stress and human disease. Toxicology 283(2–3), 65–87 (2011)PubMedCrossRef
3.
go back to reference G. Loudianos et al., Further delineation of the molecular pathology of Wilson disease in the Mediterranean population. Hum. Mutat. 12(2), 89–94 (1998)PubMedCrossRef G. Loudianos et al., Further delineation of the molecular pathology of Wilson disease in the Mediterranean population. Hum. Mutat. 12(2), 89–94 (1998)PubMedCrossRef
Metadata
Title
Wilson disease, genotype and infertility: is there a correlation?
Authors
Rim Frikha
Nouha Bouayed Abdelmoula
Tarek Rebai
Publication date
01-08-2013
Publisher
Springer US
Published in
Endocrine / Issue 1/2013
Print ISSN: 1355-008X
Electronic ISSN: 1559-0100
DOI
https://doi.org/10.1007/s12020-012-9872-z

Other articles of this Issue 1/2013

Endocrine 1/2013 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine